IMAX Corporation
NYSE:IMAXEntertainment
+$0.46 today
- Market cap
- $2.58B
- Beta
- 0.37
- P/E (TTM)
- 65.9
- EPS (TTM)
- $0.68
Volume 0.95M
Average 1.13M
IMAX Common Stock Issued
Cash raised by issuing new shares.
IMAX CorporationNYSE: IMAX
Common Stock Issued · Q3 FY2026 · quarter ended Sep 2026
Common stock issued outflow shrinks to $0
Q3 FY2026 common stock issued was $0, compared with $348.93K a year earlier. Trailing-twelve-month common stock issued was $17.87M.
Context
- Common stock issued amounted to 1.0% of revenue in FY2025, up 1.0 pp from a year earlier.
- Common stock issued increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock issued holds near $0 or moves back toward the trailing-twelve-month quarterly average of $4.47M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 4.01M USD
- Year-over-year change
- —
- 4-year CAGR
- +45.9%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.01M | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 883K | — |
Common Stock Issued vs competitors
How IMAX compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1277.6% is the highest of 5, against a peer median of +134.4%.
- Common stock issued amounts to 3.7% of revenue for IMAX, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $165M USD | -2.7% | -8.4% | 3.2% | |
| LTM Jun 2026 | $103.76M USD | +1143.1% | +638.1% | 2609.0% | |
| LTM Sep 2026 | $17.87M USD | +1277.6% | — | 3.7% | |
| LTM Jun 2026 | $7M USD | — | — | 0.7% | |
| LTM Jun 2026 | $6M USD | — | — | 0.2% | |
| LTM Mar 2026 | $1.58M USD | -41.7% | — | 0.0% | |
| LTM Sep 2026 | $832K USD | +271.4% | — | 0.1% | |
| LTM Jul 2026 | $0 USD | — | — | 0.0% | |
| LTM Dec 2025 | CN¥0 CNY | — | -94.3% | 0.0% | |
| Peer median (excluding IMAX) | — | +134.4% | -8.4% | 0.2% | |
Competitors are the stored peer set for IMAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (9.58M) | (19.88M) | 33.07M | 32.7M | 45.53M |
| Depreciation & Amortization | 56.08M | 56.66M | 60.02M | 65.5M | 62.45M |
| Deferred Income Tax | 3M | (2.07M) | (1.45M) | (5.63M) | 772K |
| Stock-Based Compensation | 26.08M | 27.57M | 24.23M | 23.21M | 26.82M |
| Change in Working Capital | (64.76M) | (64.9M) | (62.46M) | (47.02M) | (36.38M) |
| Accounts Receivables | (63M) | (22.93M) | (19.6M) | 20.67M | (1.32M) |
| Inventory | 11.45M | (5.53M) | (285K) | (1.5M) | (76K) |
| Accounts Payables | (4.75M) | 8.5M | (535K) | (6.38M) | 0 |
| Other Working Capital | (8.46M) | (44.94M) | (42.04M) | (59.8M) | (34.98M) |
| Other Non-Cash Items | (4.76M) | 19.94M | 5.2M | 2.07M | 27.88M |
| Operating Cash Flow | 6.07M | 17.32M | 58.62M | 70.84M | 127.07M |
| Capital Expenditures | (17.78M) | (32.62M) | (32.84M) | (41.22M) | (8.17M) |
| Acquisitions (Net) | 0 | (15.94M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | (4.73M) | 0 | 0 | 0 |
| Sales of Investments | 17.77M | 0 | 1.05M | 0 | 0 |
| Other Investing Activities | (4.09M) | (4.39M) | (8.34M) | (8.45M) | (33.75M) |
| Investing Cash Flow | (7K) | (53.29M) | (31.79M) | (41.22M) | (41.92M) |
| Debt Repayment | (101.09M) | 33.32M | (13.74M) | 11.62M | (26.89M) |
| Common Stock Issued | 883K | 0 | 0 | 0 | 4.01M |
| Common Stock Repurchased | (23.97M) | (83.17M) | (26.84M) | (17.97M) | (1.45M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (8.55M) | (8.67M) | (7.95M) | 313K | (9.74M) |
| Financing Cash Flow | (132.72M) | (58.51M) | (48.53M) | (6.04M) | (34.08M) |
| Effect of Forex Changes | (1.01M) | 2.17M | 504K | 812K | (497K) |
| Net Change in Cash | (127.67M) | (92.31M) | (21.2M) | 24.39M | 50.58M |
| Free Cash Flow | (11.71M) | (15.3M) | 25.78M | 29.62M | 118.9M |
IMAX Corporation
NYSE:IMAX
Intrinsic Alpha fair value
Locked
Current Price
$46.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.